Page 88 - Read Online

Page 12 of 13 Zeng et al. Cancer Drug Resist 2024;7:31 https://dx.doi.org/10.20517/cdr.2024.57

SUMO2. Mol Cancer 2021;20:112. DOI PubMed PMC
55. Chen X, Xu W, Ma Z, et al. Circ_0000215 exerts oncogenic function in nasopharyngeal carcinoma by targeting miR-512-5p. Front
Cell Dev Biol 2021;9:688873. DOI PubMed PMC
56. Wang Y, Yan Q, Mo Y, et al. Splicing factor derived circular RNA circCAMSAP1 accelerates nasopharyngeal carcinoma
tumorigenesis via a SERPINH1/c-Myc positive feedback loop. Mol Cancer 2022;21:62. DOI PubMed PMC
57. Zhao M, Wang Y, Tan F, et al. Circular RNA circCCNB1 inhibits the migration and invasion of nasopharyngeal carcinoma through
binding and stabilizing TJP1 mRNA. Sci China Life Sci 2022;65:2233-47. DOI PubMed
58. Jiang C, Li H, Liu F, Shi L, Liu J, Li Y. Hsa_circ_0000345 inhibits cell proliferation, migration and invasion of nasopharyngeal
carcinoma cells via miR-513a-3p/PTEN axis. J Physiol Sci 2022;72:10. DOI PubMed PMC
59. Li W, Lu H, Wang H, et al. Circular RNA TGFBR2 acts as a ceRNA to suppress nasopharyngeal carcinoma progression by sponging
miR-107. Cancer Lett 2021;499:301-13. DOI PubMed
60. Mo Y, Wang Y, Wang Y, et al. Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP/c-Myc/
SRSF1 positive feedback loop. Mol Cancer 2022;21:192. DOI PubMed PMC
61. Wu P, Hou X, Peng M, et al. Circular RNA circRILPL1 promotes nasopharyngeal carcinoma malignant progression by activating the
Hippo-YAP signaling pathway. Cell Death Differ 2023;30:1679-94. DOI PubMed PMC
62. Lu X, Xie H. Circ_0001971 makes progress of oral squamous cell carcinoma by targeting miR-107/FZD4 axis. Oral Dis
2023;29:1979-90. DOI PubMed
63. Tan X, Zhou C, Liang Y, Lai YF, Liang Y. Circ_0001971 regulates oral squamous cell carcinoma progression and chemosensitivity
by targeting miR-194/miR-204 in vitro and in vivo. Eur Rev Med Pharmacol Sci 2020;24:2470-81. DOI PubMed
64. Chen F, Zhang H, Wang J. Circular RNA CircSHKBP1 accelerates the proliferation, invasion, angiogenesis, and stem cell-like
properties via modulation of microR-766-5p/high mobility group AT-hook 2 axis in laryngeal squamous cell carcinoma.
Bioengineered 2022;13:11551-63. DOI PubMed PMC
65. Wang X, Wu T, Wang P, et al. Circular RNA 103862 promotes proliferation and invasion of laryngeal squamous cell carcinoma cells
through the miR-493-5p/GOLM1 axis. Front Oncol 2020;10:1064. DOI PubMed PMC
66. Guo Y, Huang Q, Zheng J, et al. Diagnostic role of dysregulated circular RNA hsa_circ_0036722 in laryngeal squamous cell
carcinoma. Onco Targets Ther 2020;13:5709-19. DOI PubMed PMC
67. Gong H, Wu W, Fang C, He D. CircBFAR correlates with poor prognosis and promotes laryngeal squamous cell cancer progression
through miR-31-5p/COL5A1 axis. Laryngoscope Investig Otolaryngol 2022;7:1951-62. DOI PubMed PMC
68. Gao W, Guo H, Niu M, et al. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by
inhibiting autophagy through the PRKCI-Akt-mTOR pathway. Mol Cancer 2020;19:166. DOI PubMed PMC
69. Wang Z, Sun A, Yan A, et al. Circular RNA MTCL1 promotes advanced laryngeal squamous cell carcinoma progression by
inhibiting C1QBP ubiquitin degradation and mediating beta-catenin activation. Mol Cancer 2022;21:92. DOI PubMed PMC
70. Gong L, Chen J, Jiang X. Circ_0005033 is an oncogene in laryngeal squamous cell carcinoma and regulates cell progression and
Cisplatin sensitivity via miR-107/IGF1R axis. Anticancer Drugs 2022;33:245-56. DOI PubMed
71. Yang H, Yu G, Wang Y, Guo X. Circ_0044520 regulates the progression of laryngeal squamous cell carcinoma via the miR-338-3p/
ROR2 axis. Histol Histopathol 2022;37:513-26. DOI PubMed
72. Zheng Y, Duan L, Yang Y, Luo D, Yan B. Circ_0023028 contributes to the progression of laryngeal squamous cell carcinoma by
upregulating LASP1 through miR-486-3p. Mol Cell Biochem 2021;476:2951-61. DOI PubMed
73. Chen L, Zhou H, Guan Z. CircRNA_000543 knockdown sensitizes nasopharyngeal carcinoma to irradiation by targeting miR-9/
platelet-derived growth factor receptor B axis. Biochem Biophys Res Commun 2019;512:786-92. DOI PubMed
74. Zhu J, Fu Q, Shao J, et al. Regulating effect of Circ_ATRNL1 on the promotion of SOX9 expression to promote chondrogenic
differentiation of hAMSCs mediated by MiR-145-5p. J Tissue Eng Regen Med 2021;15:487-502. DOI PubMed
75. Han X, Tian R, Wang C, Li Y, Song X. CircRNAs: roles in regulating head and neck squamous cell carcinoma. Front Oncol
2022;12:1026073. DOI PubMed PMC
76. Przybylski K, Majchrzak E, Weselik L, Golusiński W. Immunotherapy of head and neck squamous cell carcinoma (HNSCC).
Immune checkpoint blockade. Otolaryngol Pol 2018;72:10-6. DOI PubMed
77. Bhatia A, Burtness B. Treating head and neck cancer in the age of immunotherapy: a 2023 update. Drugs 2023;83:217-48. DOI
PubMed
78. Ge J, Wang J, Xiong F, et al. Epstein-barr virus-encoded circular RNA circBART2.2 promotes immune escape of nasopharyngeal
carcinoma by regulating PD-L1. Cancer Res 2021;81:5074-88. DOI PubMed PMC
79. Zhang J, Hu H, Zhao Y, Zhao Y. CDR1as is overexpressed in laryngeal squamous cell carcinoma to promote the tumour’s
progression via miR-7 signals. Cell Prolif 2018;51:e12521. DOI PubMed PMC
80. Chen Y, Li Z, Liang J, et al. CircRNA has_circ_0069313 induced OSCC immunity escape by miR-325-3p-Foxp3 axes in both OSCC
cells and Treg cells. Aging 2022;14:4376-89. DOI PubMed PMC
81. Burtness B, Harrington KJ, Greil R, et al; KEYNOTE-048 Investigators. Pembrolizumab alone or with chemotherapy versus
cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a
randomised, open-label, phase 3 study. Lancet 2019;394:1915-28. DOI PubMed
82. Cohen EEW, Soulières D, Le Tourneau C, et al; KEYNOTE-040 investigators. Pembrolizumab versus methotrexate, docetaxel, or
cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3